BRENTWOOD, Tenn.--(BUSINESS WIRE)-- American HomePatient, Inc. (OTCBB: AHOM), one of the nation’s largest home health care providers, today announced its financial results for the three months ended March 31, 2010.
Revenues for the first quarter of 2010 were $67.0 million compared to $66.2 million for the first quarter of 2009, representing an increase of $0.8 million, or 1.2%. The increase in revenue is primarily attributable to growth in the Company’s core respiratory product lines of oxygen and sleep therapy, partially offset by reductions in revenue associated with non-respiratory home medical equipment and infusion therapy as a result of the Company’s continued reduction in emphasis of these less profitable product lines.
Operating expenses declined in the first quarter of 2010 compared to the first quarter of 2009 by approximately $0.6 million, or 1.7%. The decrease in operating expenses were primarily the result of improved operating efficiencies.
Earnings before interest, taxes, depreciation, and amortization (EBITDA) is a non-GAAP financial measurement that is calculated as net income excluding interest, taxes, depreciation and amortization. Adjusted EBITDA (EBITDA excluding debt restructuring expenses) was $8.0 million, or 11.9% of net revenue, for the first quarter of 2010 compared to $7.3 million, or 11.1% of net revenue, for the same period of 2009.
Net loss for the first quarter of 2010 was $(3.8) million, or $(0.21) per diluted share, compared to net loss of $(5.2) million, or $(0.29) per diluted share, for the first quarter of 2009.
Prior to January 1, 2010, the Company accounted for its 50%-owned joint ventures as equity investments. Effective January 1, 2010, the Company began consolidating its 50%-owned joint ventures as a result of the Company’s adoption of Accounting Standards Update 2009-17, which is effective for periods beginning after December 15, 2009. For comparative purposes, prior period financial statements have been revised to reflect consolidation of the 50%-owned joint ventures retrospectively.
Secured Debt Maturity and Restructuring Transactions
The Company had secured debt of $226.4 million that was due to be repaid on August 1, 2009. As previously announced, the Company has entered into an agreement with its senior debt holders and its largest stockholder, an investment fund managed by Highland Capital Management, to complete transactions that are intended to result in a going-private transaction followed by a restructuring of the Company’s secured debt. The restructuring agreement contemplates that the Company will seek shareholder approval to reincorporate in Nevada, and, if approved, the Nevada entity will commence a tender offer to acquire all outstanding shares of stock not held by Highland managed accounts for $0.67 per share. If these transactions are completed, the stock of American HomePatient would cease to be publicly traded.
American HomePatient, Inc. is one of the nation’s largest home health care providers with operations in 33 states. Its product and service offerings include respiratory services, infusion therapy, parenteral and enteral nutrition, and medical equipment for patients in their home. American HomePatient, Inc.’s common stock is currently traded in the over-the-counter market or, on application by broker-dealers, in the NASD’s Electronic Bulletin Board under the symbol AHOM or AHOM.OB.
American HomePatient, Inc. prepares its financial statements in accordance with U.S. generally accepted accounting principles (GAAP). American HomePatient, Inc. also provides information related to non-GAAP financial measurements such as EBITDA, and from time to time, other non-GAAP financial measurements that adjust for certain items outside of the ordinary course of its business. To enable interested parties to reconcile non-GAAP measures to the Company’s GAAP financial statements, the Company clearly defines EBITDA and quantifies all other adjustments to GAAP measurements (see Schedule B). The Company provides EBITDA information, a widely used non-GAAP financial measurement, as a performance measure to assist in analyzing the Company’s operations and in comparing the Company to its competitors. The Company provides other non-GAAP financial measurements that adjust for certain items outside of the ordinary course of business in order to assist in comparing the Company’s current operating performance to its historical performance. These adjustments typically reflect non-recurring items but sometimes reflect items, such as dispositions of assets and restructuring charges that are not technically non-recurring but are outside of the ordinary course of operations. Investors should note that such measures may not be comparable to similarly titled measures used by other companies, and investors are encouraged to use this information only in connection with the information contained in the Company’s GAAP financial statements.
Certain statements made in this press release may constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements are based on management’s current expectations and include known and unknown risks, uncertainties and other factors, many of which the Company is unable to predict or control, that may cause the Company’s actual results or performance to materially differ from any future results or performance expressed or implied by such forward-looking statements. These statements involve risks and uncertainties, including, without limitation, risks and uncertainties regarding the maturity of the Company’s secured debt, current and future reimbursement rates, and reimbursement reductions and the Company’s ability to mitigate the impact of the reductions. These risks and uncertainties are in addition to risks, uncertainties, and other factors detailed from time to time in the Company’s filings with the Securities and Exchange Commission. The Company cautions investors that any forward-looking statements made by the Company are not necessarily indicative of future performance. The Company is not responsible for updating the information contained in this press release beyond the published date, or for changes made to this document by wire services or Internet services.
|
American HomePatient, Inc. |
Schedule A |
|||||||||
|
Summary Financial Data |
||||||||||
| (In thousands, except per share data) | ||||||||||
| Three Months Ended March 31, | ||||||||||
| 2010 | 2009 | |||||||||
| (unaudited) | ||||||||||
| Revenues, net | $ | 67,005 | $ | 66,160 | ||||||
| Cost of sales and related services | 14,569 | 14,378 | ||||||||
| Cost of rentals and other revenues, including rental equipment depreciation | 8,065 | 8,568 | ||||||||
| Operating expenses | 34,457 | 35,065 | ||||||||
| Bad debt expense | 1,796 | 1,296 | ||||||||
| General and administrative expenses | 5,116 | 5,126 | ||||||||
| Depreciation, excluding rental equipment, and amortization | 932 | 1,024 | ||||||||
| Interest expense, net | 3,798 | 3,866 | ||||||||
| Other (income) expense | (87 | ) | 14 | |||||||
| Change of control income | (3 | ) | (3 | ) | ||||||
| Loss from operations before income taxes | (1,638 | ) | (3,174 | ) | ||||||
| Provision for income taxes | 1,135 | 1,164 | ||||||||
| Net loss | (2,773 | ) | (4,338 | ) | ||||||
| Less: Net income attributable to the noncontrolling interest | (996 | ) | (830 | ) | ||||||
| Net loss attributable to American HomePatient, Inc. | $ | (3,769 | ) | $ | (5,168 | ) | ||||
| Basic loss per common share attributable to American HomePatient, Inc common shareholders | $ | (0.21 | ) | $ | (0.29 | ) | ||||
| Diluted loss per common share attributable to American HomePatient, Inc common shareholders | $ | (0.21 | ) | $ | (0.29 | ) | ||||
| March 31, | December 31, | |||||||||
| 2010 | 2009 | |||||||||
| (unaudited) | ||||||||||
| Cash and cash equivalents | $ | 19,832 | $ | 23,613 | ||||||
| Restricted cash | - | 250 | ||||||||
| Net patient receivables | 32,066 | 29,447 | ||||||||
| Other receivables | 336 | 521 | ||||||||
| Total receivables | 32,402 | 29,968 | ||||||||
| Net inventories | 11,039 | 12,240 | ||||||||
| Other current assets | 5,805 | 6,690 | ||||||||
| Total current assets | 69,078 | 72,761 | ||||||||
| Property and equipment, net | 33,483 | 33,790 | ||||||||
| Goodwill | 123,621 | 123,621 | ||||||||
| Other assets | 16,531 | 16,977 | ||||||||
| Total Assets | $ | 242,713 | $ | 247,149 | ||||||
| Current portion of long-term debt and capital leases | $ | 227,327 | $ | 229,120 | ||||||
| Accounts payable | 15,148 | 14,153 | ||||||||
| Other current liabilities | 21,809 | 21,765 | ||||||||
| Total current liabilities | 264,284 | 265,038 | ||||||||
| Long-term debt and capital leases, less current portion | - | 3 | ||||||||
| Deferred tax liability | 13,026 | 12,031 | ||||||||
| Other noncurrent liabilities | 101 | 82 | ||||||||
| Total liabilities | 277,411 | 277,154 | ||||||||
| American HomePatient, Inc. shareholders' deficit | (41,908 | ) | (37,411 | ) | ||||||
| Noncontrolling interest | 7,210 | 7,406 | ||||||||
| Total shareholders' deficit | (34,698 | ) | (30,005 | ) | ||||||
| Total Liabilities and Shareholders' Deficit | $ | 242,713 | $ | 247,149 | ||||||
| American HomePatient, Inc. |
Schedule B |
|||||||||
|
Reconciliation of Non-GAAP Financial Measurements to GAAP Financial Statements |
||||||||||
| (In thousands) | ||||||||||
| Three Months Ended March 31, | ||||||||||
| 2010 | 2009 | |||||||||
| (unaudited) | ||||||||||
| Net loss | $ | (3,769 | ) | $ | (5,168 | ) | ||||
| Add: | ||||||||||
| Provision for income taxes | 1,135 | 1,164 | ||||||||
| Interest expense, net | 3,798 | 3,866 | ||||||||
| Rental equipment depreciation | 5,769 | 6,410 | ||||||||
| Other depreciation and amortization | 932 | 1,024 | ||||||||
| Earnings before interest, taxes, depreciation, and amortization (EBITDA) | $ | 7,865 | $ | 7,296 | ||||||
| Debt restructuring expense (Note A) | 90 | 31 | ||||||||
| Adjusted EBITDA | $ | 7,955 | $ | 7,327 | ||||||
| Note A: Debt restructuring expense is excluded to determine adjusted EBITDA, as the expense is non-recurring. | ||||||||||
CONTACT:
American HomePatient, Inc.
Joseph F. Furlong, President and CEO, 615-221-8884
or
Primary Contact:
Stephen L. Clanton, Executive VP & CFO, 615-221-8884
KEYWORDS: United States North America Tennessee
INDUSTRY KEYWORDS: Health Hospitals Other Health Nursing General Health Managed Care
MEDIA: